Assessment of Short-Term Effects of Cell Transplantation in Cirrhosis DUE to HCV
Recent studies have highlighted the potential of fetal hepatic stem cells in regenerative treatments for liver diseases. This study aimed to evaluate the short-term effects of fetal stem cell transplantation in patients with liver cirrhosis resulting from chronic hepatitis C. Thirty patients with li...
Saved in:
Published in | Asian Pacific journal of cancer prevention : APJCP Vol. 25; no. 6; pp. 2099 - 2104 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Thailand
West Asia Organization for Cancer Prevention
01.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recent studies have highlighted the potential of fetal hepatic stem cells in regenerative treatments for liver diseases. This study aimed to evaluate the short-term effects of fetal stem cell transplantation in patients with liver cirrhosis resulting from chronic hepatitis C.
Thirty patients with liver cirrhosis of all Child-Turcotte-Pugh classes due to chronic hepatitis C, aged 18 to 65 years, were selected for this study. A single intravenous dose of 1 ml containing 6*106 fetal hepatic stem cells, diluted in 20.0 ml of 0.9% sodium chloride solution, was administered. The efficacy of the treatment was assessed by measuring levels of ALT, AST, total and direct bilirubin, gamma-glutamyltranspeptidase, alkaline phosphatase, total protein, and albumin before and after cell therapy.
Post-treatment, a significant reduction was noted in the Child-Pugh score from 8 [6-9] to 7 [6-8] (p<0.001) and the MELD index from 11 [7-15] to 10 [7-14] (p=0.004). Skin itching decreased from 36.7% to 10%. Complaints of weakness increased significantly from 3.3% to 23.3% after 30 days of therapy (p=0.014), and the incidence of reduced appetite increased from 20% to 46.7% (p=0.021). No statistical differences were observed in the frequency of nosebleeds (86.7% initially vs. 90% at day 30, p=0.655) or drowsiness (63.3% initially vs. 76.7% at day 30, p=0.157). Significant reductions were noted in ALT levels by 35% and total bilirubin by 44%. The lack of significant changes in indicators of hepatic-cell insufficiency, particularly the protein-forming function as reflected in total protein and albumin levels, is likely due to the extent of liver tissue damage and thus a delayed recovery.
The findings of this study affirm the clinical efficacy and promise of fetal hepatic stem cell therapy as part of a comprehensive treatment regimen for patients with liver cirrhosis. |
---|---|
AbstractList | Recent studies have highlighted the potential of fetal hepatic stem cells in regenerative treatments for liver diseases. This study aimed to evaluate the short-term effects of fetal stem cell transplantation in patients with liver cirrhosis resulting from chronic hepatitis C.
Thirty patients with liver cirrhosis of all Child-Turcotte-Pugh classes due to chronic hepatitis C, aged 18 to 65 years, were selected for this study. A single intravenous dose of 1 ml containing 6*106 fetal hepatic stem cells, diluted in 20.0 ml of 0.9% sodium chloride solution, was administered. The efficacy of the treatment was assessed by measuring levels of ALT, AST, total and direct bilirubin, gamma-glutamyltranspeptidase, alkaline phosphatase, total protein, and albumin before and after cell therapy.
Post-treatment, a significant reduction was noted in the Child-Pugh score from 8 [6-9] to 7 [6-8] (p<0.001) and the MELD index from 11 [7-15] to 10 [7-14] (p=0.004). Skin itching decreased from 36.7% to 10%. Complaints of weakness increased significantly from 3.3% to 23.3% after 30 days of therapy (p=0.014), and the incidence of reduced appetite increased from 20% to 46.7% (p=0.021). No statistical differences were observed in the frequency of nosebleeds (86.7% initially vs. 90% at day 30, p=0.655) or drowsiness (63.3% initially vs. 76.7% at day 30, p=0.157). Significant reductions were noted in ALT levels by 35% and total bilirubin by 44%. The lack of significant changes in indicators of hepatic-cell insufficiency, particularly the protein-forming function as reflected in total protein and albumin levels, is likely due to the extent of liver tissue damage and thus a delayed recovery.
The findings of this study affirm the clinical efficacy and promise of fetal hepatic stem cell therapy as part of a comprehensive treatment regimen for patients with liver cirrhosis. |
Author | Saparbayev, Samat Iskakova, Aigerim Kurmangazin, Meirambek Nurlanova, Gulzhanat Astrakhanov, Akezhan Amanzholkyzy, Ainur |
AuthorAffiliation | West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
AuthorAffiliation_xml | – name: West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
Author_xml | – sequence: 1 givenname: Akezhan orcidid: 0000-0001-5363-3168 surname: Astrakhanov fullname: Astrakhanov, Akezhan organization: West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan – sequence: 2 givenname: Samat surname: Saparbayev fullname: Saparbayev, Samat organization: West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan – sequence: 3 givenname: Ainur orcidid: 0000-0002-1980-9032 surname: Amanzholkyzy fullname: Amanzholkyzy, Ainur organization: West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan – sequence: 4 givenname: Aigerim orcidid: 0000-0002-8022-5212 surname: Iskakova fullname: Iskakova, Aigerim organization: West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan – sequence: 5 givenname: Gulzhanat orcidid: 0000-0003-3313-514X surname: Nurlanova fullname: Nurlanova, Gulzhanat organization: West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan – sequence: 6 givenname: Meirambek orcidid: ORCID 0000-0002-1112 surname: Kurmangazin fullname: Kurmangazin, Meirambek organization: West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38918672$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkFtLAzEUhINU7EV_gpI_sGtO7vskZa1WESzYim9LmmTtyjZbklXw31vxgj7NcIb54MwYDUIXPEKnQHIGQqjz6eK2XOSUUJ5Tkcu9K4oDNKJcyUxJ-jRAIxDAMsWkHqJxSi-EcKGVOEJDpgvQUtERWkxT8iltfehxV-OHTRf7bOnjFs_q2ts-fV5L37Z4GU1Iu9aE3vRNF3ATcNnEuOlSk_Dlaob7Ds_Lx2N0WJs2-ZNvnaDV1WxZzrO7--ubcnqXWUpEkQniORiwEqC2hBTgnNWaUg-WO8eYXPO1tlyAkmCE89YDrxVTjjtau0KwCbr44u5e11vv7P6BaNpqF5utie9VZ5rqfxKaTfXcvVUATFMtyZ5w9pfwW_0Zh30A5rBqYA |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM 5PM |
DOI | 10.31557/APJCP.2024.25.6.2099 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2476-762X |
EndPage | 2104 |
ExternalDocumentID | 38918672 |
Genre | Journal Article |
GroupedDBID | CGR CUY CVF ECM EIF NPM --- 23N 2WC 53G 5GY 5PM 9ZL ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK E3Z EBS EJD F5P FRJ GROUPED_DOAJ GX1 HYE JDI OK1 RPM TR2 W2D WOW |
ID | FETCH-LOGICAL-c2059-50e41a1c611fc0091ddc8822e1c4dd336b4b8c451761a5dece14f737d4d2fd953 |
IEDL.DBID | RPM |
ISSN | 1513-7368 |
IngestDate | Wed Sep 11 06:03:53 EDT 2024 Wed Oct 23 09:51:50 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | fetal stem cells Liver Cirrhosis Hepatitis C cell therapy |
Language | English |
License | This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. https://creativecommons.org/licenses/by-nc/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2059-50e41a1c611fc0091ddc8822e1c4dd336b4b8c451761a5dece14f737d4d2fd953 |
ORCID | 0000-0002-1980-9032 0000-0003-3313-514X ORCID 0000-0002-1112 0000-0002-8022-5212 0000-0001-5363-3168 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11382860/ |
PMID | 38918672 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11382860 pubmed_primary_38918672 |
PublicationCentury | 2000 |
PublicationDate | 2024-Jun-01 |
PublicationDateYYYYMMDD | 2024-06-01 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-Jun-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Thailand |
PublicationPlace_xml | – name: Thailand – name: Iran |
PublicationTitle | Asian Pacific journal of cancer prevention : APJCP |
PublicationTitleAlternate | Asian Pac J Cancer Prev |
PublicationYear | 2024 |
Publisher | West Asia Organization for Cancer Prevention |
Publisher_xml | – name: West Asia Organization for Cancer Prevention |
SSID | ssj0045875 |
Score | 2.4196913 |
Snippet | Recent studies have highlighted the potential of fetal hepatic stem cells in regenerative treatments for liver diseases. This study aimed to evaluate the... |
SourceID | pubmedcentral pubmed |
SourceType | Open Access Repository Index Database |
StartPage | 2099 |
SubjectTerms | Adolescent Adult Aged Female Follow-Up Studies Hepacivirus Hepatitis C, Chronic - complications Humans Liver Cirrhosis - therapy Male Middle Aged Prognosis Stem Cell Transplantation - methods Young Adult |
Title | Assessment of Short-Term Effects of Cell Transplantation in Cirrhosis DUE to HCV |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38918672 https://pubmed.ncbi.nlm.nih.gov/PMC11382860 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Ja8JAFMcH9VB6Kd1rF5lDr9FMZs1R0ooISqBavElmCQY0itrv35mMkXrtJYdkAuG98Bbm_34DwDsPjcOGZYEUjAUkQjoQNMxtMBQxl1hqUw3SjidsOCOjOZ03AKtnYSrRvpJFt1ytu2WxrLSV27Xq1TqxXjpOkAPnCRb2mqDJMa57dB9_CRUVXtemMhxwzISf28E2cfJePx0lqe0KI9KNaNdJFGLHDXWbdYI5SvApDZ1LJP_knME1uDoWi7DvP-oGNEx5Cy7Gx-3wO5D2T1xNuMnh19LW0sHUxlroocR7dzcxqxX0DPNV5geNSliUMCl2u-VmX-zhx-wTHjZwmHzfg9ngc5oMg-MRCYGKbGEU0NAQlCHFEMqVLZeQ1srWzJFBimiNMZNECkUo4gxlVBtlEMk55proKNcxxQ-gVW5K8wRgLkMtslDHdjVBhGeSK66oYFlMhWaqDR69SRZbz8FY1FZrA3FmrNMCh64-f2I9WiGsaw8-___VF3Dp_OhlW6-gddj9mDdbIBxkp2qs7XWSjjvVv_ELiwa6rg |
link.rule.ids | 230,315,733,786,790,870,891,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3bT9swFMaPWJE2XrhtjDLY_MBr0jjxLY9VBiqXokq0G29VfIkaraSoLS_89dhxU9G9wWvsSIntnPNZ_s4vAOc8Mg4blgdSMBaQGOtA0KiwwVCkXCZSm7qQtn_HeiNy_UAftoA1tTC1aV_JMqymj2FVTmpv5dOj6jQ-sc6gn2EHzhMs6nyCbfvBxrTZpfsITKioAbs2mSUBT5jwlTuJTZ280x1cZwO7L4xJGNPQmRRSRw51x3WCOU7wOhFtmiTfZJ3LPfjbPK83m_wLn5cyVC__oRzf_0L7sLsSoqjr2w9gy1SH8Lm_Omr_CoPumtmJZgW6n1idHgxtHEceeLxwVzMznSLPR5_mvoipQmWFsnI-n8wW5QL9Hl2g5Qz1sj_fYHR5Mcx6wer3C4GKregKaGQIzrFiGBfKSjGstbJ6PDZYEa2ThEkihSIUc4Zzqo0ymBQ84ZrouNApTY6gVc0qcwyokJEWeaRT25tgwnPJFVdUsDylQjPVhu9-sMdPnrExbuajDWJjGtYdHBZ7s8UObo3Hbgbz5OO3_oIvvWH_dnx7dXfzA3bcavH2sFNoLefP5swKkaX8Wa-6V7P92tE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3LT-MwEIctKBLiwmPZ5c36wDUPJ37lWAWqAlsUaekKaQ9V_IgaUdKqjwt_PXacVJQj12QiJWNnZiz_5jMANyzUFhuWe4JT6uEIKY-TsDDBkCdMxELpupF28ET7Q_zwQl4aVeWikVVWUpR-NXnzq3JcaytnbzJodWJBNkiRBedxGgYzVQTbYMf8tBFrV-ouCmPCa8iuSWixx2LKXfdObNInC7rZQ5qZtWGE_Yj4VqiQWHqo3bLj1LKC18loUyj5KfP0DsD_9p2d4OTVXy2FL9-_4By_91GHYL8pSGHX2RyBLV39ALuDZsv9GGTdNbsTTgv4d2zqde_ZxHPowMcLezXVkwl0nPRJ7pqZKlhWMC3n8_F0US7g7fAOLqewn_77CYa9u-e07zXHMHgyMsWXR0KNUY4kRaiQpiRDSklTl0caSaxUHFOBBZeYIEZRTpSWGuGCxUxhFRUqIfEv0KmmlT4FsBCh4nmoEmONEWa5YJJJwmmeEK6oPAMnzuGjmWNtjNoxOQN8YyjWBhaPvXnHOLjGZLcOPf_-o7_BbnbbG_25f3q8AHt2wjiV2CXoLOcrfWXqkaW4rifeB7RH3VE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+Short-Term+Effects+of+Cell+Transplantation+in+Cirrhosis+DUE+to+HCV&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Astrakhanov%2C+Akezhan&rft.au=Saparbaev%2C+Samat&rft.au=Amanzholkyzy%2C+Ainur&rft.au=Iskakova%2C+Aigerim&rft.date=2024-06-01&rft.pub=West+Asia+Organization+for+Cancer+Prevention&rft.issn=1513-7368&rft.eissn=2476-762X&rft.volume=25&rft.issue=6&rft.spage=2099&rft.epage=2104&rft_id=info:doi/10.31557%2FAPJCP.2024.25.6.2099&rft_id=info%3Apmid%2F38918672&rft.externalDBID=PMC11382860 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1513-7368&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1513-7368&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1513-7368&client=summon |